A pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorder
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background: Both psychodynamic group therapy (PGT) and clonazepam are used as treatment strategies in reducing symptoms of generalized social anxiety disorder (GSAD). However, many individuals remain symptomatic after treatment with PGT or clonazepam. Method: Fifty-eight adult outpatients with a diagnosis of GSAD according to DSM-IV were randomized to 12 weeks PGT plus clonazepam or clonazepam. The Clinical Global Impression-Improvement (CGI-I) Scale was the primary efficacy measure. Secondary efficacy measures included the Liebowitz Social Anxiety Scale (LSAS) total score, the World Health Organization Instrument to Assess Quality of Life—Brief (WHOQOL-Bref) Scale and the Beck Depression Inventory (BDI). Results: CGI-I data from 57 patients (intent-to-treat population) showed that patients who received PGT plus clonazepam presented significantly greater improvement than those who received clonazepam (P = 0.033). There were no significant differences between the two groups in the secondary efficacy measures. Conclusions: Our study suggests that the combination of PGT with clonazepam may be a promising strategy for the treatment of GSAD, regarding gains in the global functioning. However the present study failed to detect more specific changes in social anxiety symptomatology between the two groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Linear Mixed Models for Longitudinal Data
Verbeke, G. (1997) · Lecture Notes in Statistics · doi:10.1007/978-1-4612-2294-1_3 · Cited by 3,506
Liebowitz, M. R. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000414022 · Cited by 2,266
Fleck, M. P., Louzada, S., Xavier, M., Chachamovich, E., Vieira, G., Santos, L., & Pinzon, V. (2000) · Revista de Saúde Pública · doi:10.1590/s0034-89102000000200012 · Cited by 1,933
Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422001 · Cited by 1,331 · cited 4×
“Neither MDD nor Panic Disorder as comorbidities were associated with treatment outcome (data not shown).”
ResultInfluentialFoa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.151 · Cited by 1,048
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000) · JAMA · doi:10.1001/jama.283.19.2529 · Cited by 953
FRESCO, D. M., COLES, M. E., HEIMBERG, R. G., LIEBOWITZ, M. R., HAMI, S., STEIN, M. B., & GOETZ, D. (2001) · Psychological Medicine · doi:10.1017/s0033291701004056 · Cited by 874 · cited 1×
“In the present study the LSAS-SR was administered with instructions read to the patients prior to the administration of the scale [4,10,22].”
MethodLinear mixed models for longitudinal data
(2000) · Springer Series in Statistics · doi:10.1007/b98969 · Cited by 818
The Liebowitz social anxiety scale as a self-report instrument: a preliminary psychometric analysis
Baker, S. L., Heinrichs, N., Kim, H.-J., & Hofmann, S. G. (2002) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(01)00060-2 · Cited by 640 · cited 1×
“In the present study the LSAS-SR was administered with instructions read to the patients prior to the administration of the scale [4,10,22].”
MethodCognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia: 12-Week Outcome
Heimberg, R. G., Liebowitz, M. R., Hope, D. A., Schneier, F. R., Holt, C. S., Welkowitz, L. A., Juster, H. R., Campeas, R., Bruch, M. A., Cloitre, M., et al. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1133 · Cited by 585
The treatment of social anxiety disorder
Rodebaugh, T. L., Holaway, R. M., & Heimberg, R. G. (2004) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.07.007 · Cited by 424 · cited 2×
“Secondary efficacy measures included the proportion of responders (defined as CGI-I 2, ‘‘much’’ or ‘‘very much improved’’, based only on social anxiety symptoms) and the percentage of patients in full remission according to two different definitions: (a) LSAS total score 30; (b) CGI-I score of 1 [49].”
BackgroundMethodFluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia
Davidson, J. R. T., Foa, E. B., Huppert, J. D., Keefe, F. J., Franklin, M. E., Compton, J. S., Zhao, N., Connor, K. M., Lynch, T. R., & Gadde, K. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.1005 · Cited by 415 · cited 12×
“[16] conducted a randomized trial (n 1⁄4 295) to examine improvement in response rates with the addition of fluoxetine to CBT and found that, addition of fluoxetine resulted in less than 3% incremental improvement of the combined treatment group over the CBT group, suggesting that combined treatment did not yield any…”
BackgroundMethodInfluentialPsychological and Pharmacological Treatments of Social Phobia: A Meta-Analysis
Fedoroff, I. C., & Taylor, S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00011 · Cited by 396 · cited 10×
“Future studies should investigate the effect of longer treatment periods, examine the efficacy of combining PGT with different medications, and compare PGT versus CBT as a strategy for the treatment of GSAD.”
BackgroundInfluentialA randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder
Milrod, B., Leon, A. C., Busch, F., Rudden, M., Schwalberg, M., Clarkin, J., Aronson, A., Singer, M., Turchin, W., Klass, E. T., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.265 · Cited by 323 · cited 1×
“Although psychodynamic psychotherapy has been shown in other disorders [8,34,43,45,59], there is only one published study suggesting its efficacy in GSAD [33].”
Otto, M. W., Pollack, M. H., Gould, R. A., Worthington, J. J., McArdle, E. T., Rosenbaum, J. F., & Heimberg, R. G. (2000) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(00)00027-x · Cited by 175 · cited 2×
“We chose clonazepam based on the promising results of prior studies [14,29,46,52,57], as well as relapse prevention effects with long-term clonazepam treatment in SAD [9].”
BackgroundPsychological Treatments for Social Phobia
Rowa, K., & Antony, M. M. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000603 · Cited by 65 · cited 10×
“Future studies should investigate the effect of longer treatment periods, examine the efficacy of combining PGT with different medications, and compare PGT versus CBT as a strategy for the treatment of GSAD.”
BackgroundInfluentialSwinson, R. P. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000601 · Cited by 17
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Leichsenring, F., & Leweke, F. (2017) · New England Journal of Medicine · doi:10.1056/nejmcp1614701 · Cited by 256
Dell’osso, B., & Lader, M. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2011.11.003 · Cited by 210
“[90] in a study with 58 adult outpatients with GAD,”
BackgroundBarkowski, S., Schwartze, D., Strauss, B., Burlingame, G. M., Barth, J., & Rosendahl, J. (2016) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2016.02.005 · Cited by 134
Wong, J., Gordon, E. A., & Heimberg, R. G. (2012) · Handbook of Evidence-Based Practice in Clinical Psychology · doi:10.1002/9781118156391.ebcp002027 · Cited by 96
Metadata
- Authors
- Knijnik, D. Z., Blanco, C., Salum, G. A., Moraes, C. U., Mombach, C., Almeida, E., Pereira, M., Strapasson, A., Manfro, G. G., & Eizirik, C. L.
- Venue
- European Psychiatry
- Publisher
- Cambridge University Press (CUP)
- Published
- 2008-12
- Volume
- 23
- Issue
- 8
- Pages
- 567-574
- ISSN
- 0924-9338 (ISSN-L)
- 1778-3585
- OpenAlex
- W2020479370
- Cited by
- 53
- References
- 17
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.